☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
astraZeneca
AstraZeneca’s Fasenra Receives NMPA’s Approval to Treat Severe Eosinophilic Asthma
August 21, 2024
AstraZeneca's Imfinzi Gets the US FDA Priority Review and BTD for LS-SCLC
August 16, 2024
AstraZeneca’s Lynparza Plus Imfinzi Receives the EC’s Approval to Treat Endometrial Cancer
August 14, 2024
AstraZeneca and Daiichi Sankyo’s Enhertu Receives the NMPA’s Conditional Approval to Treat Gastric Cancer
August 13, 2024
PharmaShots Weekly Snapshots (July 29 – August 02, 2024)
August 2, 2024
AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia
July 29, 2024
Load more...
Back to Home